Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization

Alexander V. Ljubimov, Sergio Caballero, Annette M. Aoki, Lorenzo A. Pinna, Maria B. Grant, Raquel Castellon

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

PURPOSE. The purpose of the study was to characterize signaling intermediates involved in angiogenic responses of retinal endothelial cells (RECs) to the extracellular matrix and growth factors, by using specific inhibitors. METHODS. Tubelike structure formation and the development of secondary sprouts on a basement membrane (BM) matrix, cell proliferation, and cell migration were studied in cultures of bovine and human RECs. Specific inhibitors were tested for inhibition of retinal neovascularization in a mouse model of oxygen-induced retinopathy (OIR). RESULTS. In initial experiments, the broad-spectrum protein kinase inhibitors, H7 and H89, stabilized REC tubes on BM matrix and inhibited secondary sprouting, cell migration, and cell proliferation. Among more specific kinase inhibitors tested, only inhibitors of protein kinase CK2 (formerly, casein kinase II), such as emodin and DRB, were able to duplicate the effects of H7 and H89. Actinomycin D caused only minor changes in angiogenic assays, suggesting that CK2's effects on REC did not involve its known impact on transcription. The extent of retinal neovascularization in a mouse OIR model was reduced >70% (versus untreated or vehicle-treated groups) after treatment with emodin (6 days at 60 mg/kg per day) and by approximately 60% after treatment at the same dose with TBB, the most specific CK2 inhibitor known. In the treated retinas, the main vascular tree had minimal changes, but the neovascular tufts were greatly reduced in number or absent. CONCLUSIONS. This is the first demonstration of the involvement of ubiquitous protein kinase CK2 in angiogenesis. Naturally derived CK2 inhibitors may be useful for treatment of proliferative retinopathies.

Original languageEnglish (US)
Pages (from-to)4583-4591
Number of pages9
JournalInvestigative Ophthalmology and Visual Science
Volume45
Issue number12
DOIs
StatePublished - Dec 2004
Externally publishedYes

Fingerprint

Retinal Neovascularization
Casein Kinase II
Endothelial Cells
Emodin
Basement Membrane
Cell Movement
Cell Proliferation
Dichlororibofuranosylbenzimidazole
Oxygen
Dactinomycin
Protein Kinase Inhibitors
Extracellular Matrix
Blood Vessels
Retina
Intercellular Signaling Peptides and Proteins
Phosphotransferases
N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Ljubimov, A. V., Caballero, S., Aoki, A. M., Pinna, L. A., Grant, M. B., & Castellon, R. (2004). Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization. Investigative Ophthalmology and Visual Science, 45(12), 4583-4591. https://doi.org/10.1167/iovs.04-0686

Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization. / Ljubimov, Alexander V.; Caballero, Sergio; Aoki, Annette M.; Pinna, Lorenzo A.; Grant, Maria B.; Castellon, Raquel.

In: Investigative Ophthalmology and Visual Science, Vol. 45, No. 12, 12.2004, p. 4583-4591.

Research output: Contribution to journalArticle

Ljubimov, AV, Caballero, S, Aoki, AM, Pinna, LA, Grant, MB & Castellon, R 2004, 'Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization', Investigative Ophthalmology and Visual Science, vol. 45, no. 12, pp. 4583-4591. https://doi.org/10.1167/iovs.04-0686
Ljubimov, Alexander V. ; Caballero, Sergio ; Aoki, Annette M. ; Pinna, Lorenzo A. ; Grant, Maria B. ; Castellon, Raquel. / Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization. In: Investigative Ophthalmology and Visual Science. 2004 ; Vol. 45, No. 12. pp. 4583-4591.
@article{30678076e3784e89b795ec8205575ea0,
title = "Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization",
abstract = "PURPOSE. The purpose of the study was to characterize signaling intermediates involved in angiogenic responses of retinal endothelial cells (RECs) to the extracellular matrix and growth factors, by using specific inhibitors. METHODS. Tubelike structure formation and the development of secondary sprouts on a basement membrane (BM) matrix, cell proliferation, and cell migration were studied in cultures of bovine and human RECs. Specific inhibitors were tested for inhibition of retinal neovascularization in a mouse model of oxygen-induced retinopathy (OIR). RESULTS. In initial experiments, the broad-spectrum protein kinase inhibitors, H7 and H89, stabilized REC tubes on BM matrix and inhibited secondary sprouting, cell migration, and cell proliferation. Among more specific kinase inhibitors tested, only inhibitors of protein kinase CK2 (formerly, casein kinase II), such as emodin and DRB, were able to duplicate the effects of H7 and H89. Actinomycin D caused only minor changes in angiogenic assays, suggesting that CK2's effects on REC did not involve its known impact on transcription. The extent of retinal neovascularization in a mouse OIR model was reduced >70{\%} (versus untreated or vehicle-treated groups) after treatment with emodin (6 days at 60 mg/kg per day) and by approximately 60{\%} after treatment at the same dose with TBB, the most specific CK2 inhibitor known. In the treated retinas, the main vascular tree had minimal changes, but the neovascular tufts were greatly reduced in number or absent. CONCLUSIONS. This is the first demonstration of the involvement of ubiquitous protein kinase CK2 in angiogenesis. Naturally derived CK2 inhibitors may be useful for treatment of proliferative retinopathies.",
author = "Ljubimov, {Alexander V.} and Sergio Caballero and Aoki, {Annette M.} and Pinna, {Lorenzo A.} and Grant, {Maria B.} and Raquel Castellon",
year = "2004",
month = "12",
doi = "10.1167/iovs.04-0686",
language = "English (US)",
volume = "45",
pages = "4583--4591",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "12",

}

TY - JOUR

T1 - Involvement of protein kinase CK2 in angiogenesis and retinal neovascularization

AU - Ljubimov, Alexander V.

AU - Caballero, Sergio

AU - Aoki, Annette M.

AU - Pinna, Lorenzo A.

AU - Grant, Maria B.

AU - Castellon, Raquel

PY - 2004/12

Y1 - 2004/12

N2 - PURPOSE. The purpose of the study was to characterize signaling intermediates involved in angiogenic responses of retinal endothelial cells (RECs) to the extracellular matrix and growth factors, by using specific inhibitors. METHODS. Tubelike structure formation and the development of secondary sprouts on a basement membrane (BM) matrix, cell proliferation, and cell migration were studied in cultures of bovine and human RECs. Specific inhibitors were tested for inhibition of retinal neovascularization in a mouse model of oxygen-induced retinopathy (OIR). RESULTS. In initial experiments, the broad-spectrum protein kinase inhibitors, H7 and H89, stabilized REC tubes on BM matrix and inhibited secondary sprouting, cell migration, and cell proliferation. Among more specific kinase inhibitors tested, only inhibitors of protein kinase CK2 (formerly, casein kinase II), such as emodin and DRB, were able to duplicate the effects of H7 and H89. Actinomycin D caused only minor changes in angiogenic assays, suggesting that CK2's effects on REC did not involve its known impact on transcription. The extent of retinal neovascularization in a mouse OIR model was reduced >70% (versus untreated or vehicle-treated groups) after treatment with emodin (6 days at 60 mg/kg per day) and by approximately 60% after treatment at the same dose with TBB, the most specific CK2 inhibitor known. In the treated retinas, the main vascular tree had minimal changes, but the neovascular tufts were greatly reduced in number or absent. CONCLUSIONS. This is the first demonstration of the involvement of ubiquitous protein kinase CK2 in angiogenesis. Naturally derived CK2 inhibitors may be useful for treatment of proliferative retinopathies.

AB - PURPOSE. The purpose of the study was to characterize signaling intermediates involved in angiogenic responses of retinal endothelial cells (RECs) to the extracellular matrix and growth factors, by using specific inhibitors. METHODS. Tubelike structure formation and the development of secondary sprouts on a basement membrane (BM) matrix, cell proliferation, and cell migration were studied in cultures of bovine and human RECs. Specific inhibitors were tested for inhibition of retinal neovascularization in a mouse model of oxygen-induced retinopathy (OIR). RESULTS. In initial experiments, the broad-spectrum protein kinase inhibitors, H7 and H89, stabilized REC tubes on BM matrix and inhibited secondary sprouting, cell migration, and cell proliferation. Among more specific kinase inhibitors tested, only inhibitors of protein kinase CK2 (formerly, casein kinase II), such as emodin and DRB, were able to duplicate the effects of H7 and H89. Actinomycin D caused only minor changes in angiogenic assays, suggesting that CK2's effects on REC did not involve its known impact on transcription. The extent of retinal neovascularization in a mouse OIR model was reduced >70% (versus untreated or vehicle-treated groups) after treatment with emodin (6 days at 60 mg/kg per day) and by approximately 60% after treatment at the same dose with TBB, the most specific CK2 inhibitor known. In the treated retinas, the main vascular tree had minimal changes, but the neovascular tufts were greatly reduced in number or absent. CONCLUSIONS. This is the first demonstration of the involvement of ubiquitous protein kinase CK2 in angiogenesis. Naturally derived CK2 inhibitors may be useful for treatment of proliferative retinopathies.

UR - http://www.scopus.com/inward/record.url?scp=9444245342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=9444245342&partnerID=8YFLogxK

U2 - 10.1167/iovs.04-0686

DO - 10.1167/iovs.04-0686

M3 - Article

VL - 45

SP - 4583

EP - 4591

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 12

ER -